Elder Pharma has target of Rs 410: Thununguntla

Published on Tue, Jul 26, 2011 at 11:28 |  Source : CNBC-TV18

Updated at Tue, Jul 26, 2011 at 12:25  

1991 Investors following Elder Pharma. Share this News with them.
0
0
Share on Tumblr
Elder Pharma has target of Rs 410: Thununguntla

ALSO READ

Elder Pharma has target of Rs 410, says Jagannadham Thununguntla of SMC Global.

Thununguntla told CNBC-TV18, "Elder Pharma has target of Rs 410. It is a decent midcap pick in the pharma space and considering the current market conditions and volatility playing on a defensive midcap company. At a reasonable valuation of about 12-13 times PE multiple one year forward, in the medium-term the company can be a good rewarding stock."

Click HERE to know the rules and follow the score card

  

Trending News

Business News

Hands on Preview of the Samsung Galaxy S III
Morgan Stanley bomb: Predicts India's 2012 GDP at 5.7% "Morgan Stanley bomb: Predicts India's 2012 GDP at 5.7%"

Modi stays away from Advani, meets Vajpayee

Subir Gokarn Says Rupee Price Of Oil Has Declined

The latest earning numbers FIRST on CNBC-TV18
Videos

Jun 1 2012, 19:15

Market may dip 10-15% this month: Jeff Chowdhry

- in FII View

Jun 1 2012, 11:57

Raamdeo Agrawal lauds Q4 nos, sees drastic rate cuts ahead

- in MARKET OUTLOOK

Interviews

Jun 1 2012, 15:36 | Source: CNBC-TV18

M&M performed well on strategy, not fuel prices: Nayer  

Jun 1 2012, 11:29 | Source: CNBC-TV18

HDIL eyes revenues of Rs 2500 cr in FY13  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!